Summary
The properties ofβ 1- andβ 2-adrenoceptors in right and left atria of rat heart, and their roles in mediating chronotropic and inotropic responses toβ-adrenoceptor agonists were examined. [125I](-)-pindolol (125IPIN) bound saturably and specifically to a single class of high affinity sites in homogenates of both right and left atria. Thek 1's for association in right and left atria were 6.5×109 l/mol-min and 2.3×109 l/mol-min respectively, while thek −1's for dissociation were 0.20 min−1 and 0.17 min−1. The kinetically determinedK D's were 75 pmol/l in right and 30 pmol/l in left atria and were similar to the equilibriumK D's determined from Scatchard analysis of saturation isotherms of specific125IPIN binding. Inhibition of125IPIN binding byβ-adrenoceptor antagonists was stereoselective and the order of potency was timolol > 1-propranolol > d-propranolol > sotalol. Inhibition byβ 1- andβ 2-adrenoceptor subtype selective antagonists yielded flat displacement curves with low Hill coefficients. Nonlinear regression analysis of displacement byβ 1-selective (practolol, atenolol and metoprolol) andβ 2-selective (ICI 118,551) antagonists gave estimates of the proportion ofβ 1- andβ 2-adrenoceptors present in rat atria. Right atria contained 67±4.2%β 2-adrenoceptors and 33±4.2%β 2-adrenoceptor, while left atria contained 67±2.8%β 1- and 33±2.8%β 2-adrenoceptors. Increases in the rate of spontaneously beating right atria and the force of electrically driven left atria caused byβ-adrenoceptor agonists were also measured. pA2 values for non-subtype selectiveβ-adrenoceptor antagonists in inhibiting isoprenaline-induced increases in rate and force were highly correlated withK D values determined for specific125IPIN binding. pA2 values forβ 1- andβ 2-selective antagonists in inhibiting isoprenaline-induced increases in rate and force correlated well with the pK D values of these drugs in binding toβ 1-adrenoceptors, but not with the pK D values in binding toβ 2-adrenoceptors. Dose-response curves for stimulation of both rate and force by theβ 2-selective agonists procaterol and zinterol were shifted to a much greater extent by selective blockade ofβ 1-adrenoceptors with metoprolol than by selective blockade ofβ 2-adrenoceptors with ICI 118,551, suggesting that these compounds caused their effects by activatingβ 1-adrenoceptors. These results suggest thatβ 1- andβ 2-adrenoceptors coexist in both left and right atria of rat heart in approximately a 2∶1 ratio, however onlyβ 1-adrenoceptors mediate the chronotropic and inotropic effects ofβ-adrenoceptor agonists.
Similar content being viewed by others
References
Arunlakshana O, Schild HO (1959) Some quantitative use of drug antagonists. Br J Pharmacol 14:48–58
Barnes PJ, Nadel JA, Skoogh B-E, Roberts JM (1983) Characterization of beta adrenoceptor subtypes in canine airway smooth muscle by radioligand binding and physiological responses. J Pharmacol Exp Ther 225:456–461
Barnett DB, Rugg EL, Nahorski SR (1978) Direct evidence for two types of beta-adrenoceptor binding site in lung tissue. Nature 273:166–168
Barovsky K, Brooker G (1980) (-)-[125I]-Iodopindolol, a new highly selective radioiodinatedβ-adrenergic receptor antagonist: Measurement ofβ-receptors on intact rat astrocytoma cells. J Cyc Nucleo Res 6:297–307
Broadley KJ (1982) Cardiac adrenoceptors. J Auton Pharmacol 2:119–145
Broadley KJ, Nicholson CD (1981) Dissociation constants of isoprenaline and orciprenaline and their relative efficacies on guinea-pig isolated atria determined by use of an irreversibleβ-adrenoceptor antagonist. Br J Pharmacol 72:635–643
Brodde O-E, Leifert FJ, Krehl H-J (1982a) Coexistence ofβ 1- andβ 2-adrenoceptors in the rabbit heart: Quantitative analysis of the regional distribution by (-)-3H-dihydroalprenolol binding. J Cardiovasc Pharmacol 4:34–43
Brodde O-E, Karad K, Zerkowski H-R, Rohm N, Reidemeister JC (1982b) Demonstration ofβ 1- andβ 2-adrenoceptors in human heart by125Iodocyanopindolol (ICYP) binding. Naunyn-Schmiedeberg's Arch Pharmacol 321:R61
Brodde O-E, Karad K, Zerkowski H-R, Rohm N, Reidemeister JC (1983) Coexistence ofβ 1- andβ 2-adrenoceptors in human right atrium. Circ Res 53:752–758
Bryan LJ, Cole JJ, O'Donnell SR, Wanstell JC (1981) A study designed to explore the hypothesis that beta-1 adrenoceptors are “innervated” receptors and beta-2 adrenoceptors are “hormonal” receptors. J Pharm Exp Ther 216:395–400
Carlsson E, Ablad B, Brandstrom A, Carlsson B (1972) Differentiated blockade of the chronotropic effects of various adrenergic stimuli in the cat heart. Life Sci 11:953–958
Carlsson E, Dahlöf C-G, Hedberg A, Persson H, Tangstrand B (1977) Differentiation of cardiac chronotropic and inotropic effects ofβ-adrenoceptor agonists. Naunyn-Schmiedeberg's Arch Pharmacol 300:101–105
Carswell H, Nahorski SR (1983)β-Adrenoceptor heterogeneity in guinea-pig airways: comparison of functional and receptor labelling studies. Br J Pharmacol 79:965–971
Cheng Y-C, Prusoff WH (1973) Relationship between inhibition constant (k i) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099–3108
Cohen ML, Wiley KS (1978) Beta1 and beta2 receptor mechanisms in rat jugular veins: differences between norepinephrine and isoproterenol-induced relaxation. Life Sci 23:1997–2006
Copeland JG, Larson DF, Roeske WR, Russell DH, Womble JR (1982)β 2-Adrenoceptors regulate induction of myocardial ornithine decarboxylase in mice in vivo. Br J Pharmacol 75:479–483
Daly MJ, Long JM, Stables R (1978) The role ofβ 1- andβ 2-adrenoceptors in the inhibition of gastric acid secretion in the dog. Br J Pharmacol 64:153–157
Freyss-Beguin M, Griffaton G, Lechat P, Picken D, Quennedey MC, Rouot B, Schwartz J (1983) Comparison of the chronotropic effect and the cyclic AMP accumulation induced byβ 2-agonists in rat heart cell culture. Br J Pharmacol 78:717–723
Furchgott RF, Wakade TD, Sorace RA, Stollak JS (1975) Occurrence of both beta1 and beta2 receptors in guinea pig tracheal smooth muscle, and variation of the beta1:beta2 ratio. Fed Proc 34:794
Hancock AA, DeLean AL, Lefkowitz RJ (1979) Quantitative resolution of beta-adrenergic receptor subtypes by selective ligand binding: Application of computerized model fitting technique. Mol Pharmacol 16:1–9
Hayes R, Howard JC, Nasmyth PA (1982) The influence of drugs on the overflow of noradrenaline and the identification of receptors in guinea-pig atria. Br J Pharmacol 76:195–200
Hedberg A, Mattsson H (1981) Beta-adrenoceptor interaction of full and partial agonists in the cat heart and soleus muscle. J Pharm Exp Ther 219:798–808
Hedberg A, Minneman KP, Molinoff PB (1980) Differential distribution of beta-1 and beta-2 adrenergic receptors in cat and guinea pig heart. J Pharmacol Exp Ther 212:503–508
Heitz A, Schwartz J, Velly J (1983)β-Adrenoceptors of the human myocardium: Determination ofβ 1- andβ 2-subtypes by radioligand binding. Br J Pharmacol 80:711–717
Hoffman BB, Lefkowitz RJ (1982) Adrenergic receptors in the heart. Ann Rev Physiol 44:475–484
Homberg V, Lucas M, Rosenbaum E Vassent G, Bockaert J (1981) Presence of both bata1- and beta2-adrenergic receptors in a single cell type. Mol Pharmacol 20:463–469
Johansson K-H, Persson H (1983)β 2-Adrenoceptors in guinea pig atria. J Pharm Pharmacol 35:804–807
Kaumann AJ, Marano M (1982) On equilibrium dissociation constants for complexes of drug-receptor subtypes. Naunyn-Schmiedeberg's Arch Pharmacol 318:192–201
Kenakin TP (1982) The Schild regression in the process of receptor classification. Can J Physiol Pharmacol 60:249–265
Kenakin TP, Beek D (1980) Is prenalterol (H133/80) really a selective beta1 adrenoceptor agonist? Tissue selectivity resulting from differences in stimulus-response relationships. J Pharmacol Exp Ther 213:406–413
Kenakin TP, Beek D (1984) Relative efficacy of prenalterol and pirbuterol for beta-1 adrenoceptors. Measurement of agonist affinity by alteration of receptor number. J Pharm Exp Ther 229:340–345
Lands AM, Arnold A, McAuliff JP, Luduena FP, Brown TG (1967) Differentiation of receptor systems activated by sympathomimetic amines. Nature 214:597–598
Lau YH, Robinson RB, Rosen MR, Bilzekian JP (1980) Subclassification ofβ-adrenergic receptors in cultured rat cardiac myoblasts and fibroblasts. Circ Res 47:41–48
Minneman KP, Molinoff PB (1980) Classification and quantitation of beta adrenergic receptor subtypes. Biochem Pharmacol 29:1317–1323
Minneman KP, Hegstrand LR, Molinoff PB (1979a) The pharmacological specificity of beta-1 and beta-2 adrenergic receptors in rat heart and lung in vitro. Mol Pharmacol 16:21–33
Minneman KP, Hegstrand LR, Molinoff PB (1979b) Simultaneous determination of beta-1 and beta-2 adrenergic receptors in tissucs containing both receptor subtypes. Mol Pharmacol 16:34–46
Minneman KP, Hedberg A, Molinoff PB (1979c) Comparison of beta-adrenergic receptor subtypes in mammalian tissues. J Pharm Exp Ther 211:502–508
O'Donnel SR, Wanstall JC (1977) The use of functional antagonism to determine whetherβ-adrenoceptor agonists must have a lower efficacy than isoprenaline to be trachea-atria selective in vitro in guinea-pigs. Br J Pharmacol 60:255–262
O'Donnel SR, Wanstall JC (1979a) The importance of choice of agonist in studies designed to predictβ 2:β 1 adrenoceptor selectivity of antagonists from pA2 values on guinea-pig trachea and atria. Naunyn-Schmiedeberg's Arch Pharmacol 308:183–190
O'Donnell SR, Wanstall JC (1979b) pA2 values of selectiveβ-adrenoceptor antagonists on isolated atria demonstrate a species difference in theβ-adrenoceptor population mediating chronotropic responses in the cat and guinea-pig. J Pharmacol 31:686–690
O'Donnell SR, Wanstall JC (1981) Demonstration of bothβ 1- andβ 2-adrenoceptors mediating relaxation of isolated ring preparations of rat pulmonary artery. Br J Pharmacol 74:547–552
Rugg EL, Barnett DB, Nahorski SR (1979) Coexistence of beta1 and beta2 adrenoceptors in mammalian lung: evidence from direct binding studies. Mol Pharmacol 14:996–1005
Scatchard G (1949) The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51:600–672
Schwartz J, Velly J (1983) Theβ-adrenoceptor of pig coronary arteries: determination ofβ 1 andβ 2 subtypes by radioligand binding. Br J Pharmacol 79:409–414
Shanahan EA, Wahlquist ML, Wilmshurst EG (1979) Effects ofβ 2-adrenoceptor stimulation on cardiac metabolism in the conscious dog. Br J Pharmacol 66:229–233
Stiles GL, Taylor S, Lefkowitz RJ (1983) Human cardiac beta-adrenergic receptors: subtype heterogeneity delineated by direct radioligand binding. Life Sci 33:467–473
Vliestra RE, Blinks JR (1976) Heterogeneity of cardiac beta-adrenoceptors. Fed Proc 35:210
Zaagsma J, Oudhof R, van der Heidjen PJC, Plantje JF (1979) Subheterogeneity ofβ-adrenoceptors in the pulmonary and the cardiac system of the guinea-pig. In: Usdin E, Kopin IJ, Barchas J (eds) Catecholamines: basis and clinical frontiers. Pergamon Press, New York, pp 435–437
Author information
Authors and Affiliations
Additional information
Supported by a grant from the American Heart Association — Georgia Affiliate
Rights and permissions
About this article
Cite this article
Juberg, E.N., Minneman, K.P. & Abel, P.W. β 1- andβ 2-adrenoceptor binding and functional response in right and left atria of rat heart. Naunyn-Schmiedeberg's Arch. Pharmacol. 330, 193–202 (1985). https://doi.org/10.1007/BF00572434
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00572434